් Cellebrite Q1 '22 Earnings Call 12 May 2022 Disclaimer Use of Non-GAAP Financial Measures This Presentation includes non-GAAP financial measures. Cellebrite believes that these non-GAAP measures are useful to investors for two principal reasons. First, Collebri believes these measures may assist investors in comparing performance over various reporting periods on a consistent basis by removing from operating results he impact of items that do not reflect core operating performance. Second, these measures ...

Exhibit 99.1 Cellebrite Announces First Quarter 2022 Results ARR of $201 million, up 33% year-over-year First Quarter revenue of $62.4 million, up 17% year-over-year Reiterates 2022 outlook for 34-42% ARR growth and 16-22% revenue growth PETAH TIKVA, ISRAEL, and TYSONS CORNER, VA, May 12, 2022 – Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three months ended March 31, 2022. "We are excited to ...

Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...

් Cellebrite Q4 '21 Earnings Call 16 February 2022 Disclaimer Use of Non-GAAP Financial Measures This Presentation includes non-GAAP financial measures. Cellebrite believes that these non-GAAP measures are useful to investors for two principal reasons. First, Collebri believes these measures may assist investors in comparing performance over various reporting periods on a consistent basis by removing from operating results he impact of items that do not reflect core operating performance. Second, these meas ...

Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2021 Results Conference Call February 16, 2022 8:30 AM ET Company Participants Anat Earon-Heilborn - Vice President, Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer Conference Call Participants Jonathan Ho - William Blair Mike Cikos - Needham Shaul Eyal - Cowen Jamie Shelton - Deutsche Bank Louie DiPalma - William Blair Tal Liani - Bank of America Operator Good day and thank you for standing by. Welcome to Cellebrite Fourth ...

Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2021 Earnings Conference Call November 10, 2021 8:30 AM ET Company Participants Anat Heilborn - Vice President, Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer Conference Call Participants Shaul Eyal - Cowen Jonathan Ho - William Blair Mike Cikos - Needham Louie DiPalma - William Blair Operator Good day, ladies and gentlemen, and welcome to the Cellebrite Q3, 2021 Earnings Call. [Operator Instructions] As a reminder, this ca ...

:: Cellebrite Q3 21 Earnings Call 10 November 2021 Disclaimer Use of Non-GAAP Financial Measures This Presentation includes non-GAAP financial measures. Cellebrite believes that these non-GAAP measures are useful to investors for two principal reasons. First, Oellebri believes these measures may assist investors in comparing performance over various reporting periods on a consistent basis by removing from operating results he impact of items that do not reflect core operating performance. Second, these meas ...